【摘 要】
:
A major problem associated with current cancer therapeutics is the eventual recurrence even after the elimination of bulk of the cancer cells.Recent studies on cancer stem cells may provide a potentia
【机 构】
:
University of California at San Francisco USA
【出 处】
:
BITs 3rd Annual World Cancer Congress-2012(2012第五届世界癌症大会)
论文部分内容阅读
A major problem associated with current cancer therapeutics is the eventual recurrence even after the elimination of bulk of the cancer cells.Recent studies on cancer stem cells may provide a potential solution to this problem.We report here the identification of internalizing human single-chain antibodies(scFv) targeting Glioblastoma Multiform(GBM)tumor sphere cells.A large naive phage display antibody library was constructed and selected on the glycosylation-dependent CD 133 epitope-positive subpopulation of GBM cells grown as tumor spheres and identified internalizing scFvs that target tumor sphere cells broadly, as well as scFvs that target the CD133-positive subpopulation.These scFvs were found to be efficiently internalized by GBM tumor sphere cells.One scFv GC4 inhibited self-renewal of GBM tumor sphere cells in vitro.We have further developed a full-length human IgG1 based on this scFv, and found that it potently inhibits proliferation of GBM tumor sphere cells and GBM cells grown in regular nonselective medium.Plus, we developed a nanoparticle formulation modified with tumor-targeting GC4 single-chain antibody fragment (scFv) for systemic delivery of small interfering RNA (siRNA) and microRNA (miRNA).Taken together, these results show that internalizing human scFvs targeting tumor cells can be readily identified from a phage antibody display library, which could be useful for further development of novel therapies.
其他文献
p53 is frequently mutated by genetic alternation or suppressed by various kinds of cellular signaling pathways in human cancers.Recently, we have revealed that p53 is suppressed and eliminated from ce
Active glutamine utilization is a major biochemical feature of most tumor cells and is fundamental for the survival and proliferation of tumor cells.Glutaminolysis represents the first and rate-limiti
Epithelial mesenchymal transition and metastasis are closely related.Aberrant activation of the signaling events involved in these inter-related pathways plays a major pathophysiological role in cance
[Background]: Most clinical pathways in treating cancers in Japan are based on individual physicians personal experiences rather than on an empirical analysis of clinical data such as benchmark compar
Therapeutic Cancer Vaccines have the potential to become curative therapies for metastatic cancer.Of available cancer treatment technologies, including surgery, radiation, chemotherapy, monoclonal ant
Circulating tumor cells (CTCs) obtained noninvasively can be used as a surrogate for primary tumor cells.Indeed,CTCs are likely derived from clones in the primary tumor, suggesting that they can be us
Epithelial-mesenchymal transition (EMT) plays a central role in both physiological and pathological settings including embryogenesis, wound healing, stem cell transformation and tumor metastasis.Durin
Rituximab is a chimeric anti-CD20 antibody of IgG 1 class, with human kappa light-chain constant regions and murine light-and heavy-chain variable regions.CD20 is expressed on mostly all stages of B c
Detection and quantification of genetic mutations from circulating tumor cells (CTC) and cell free tumor DNA (ctDNA)may provide a noninvasive means for early cancer detection and disease monitoring.Ho
The role of circulating tumor cells (CTCs) has begging to be recognized the last few years.Still during time several approaches have been developed in purpose to identify, enumerate and analyze these